Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced non ...

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.

The latest news and headlines from Yahoo News. Get breaking news stories and in-depth coverage with videos and photos.

KSL is Utah's #1 source for news, sports, weather, and classifieds. Get the latest breaking news Utah cares about - today's news, current headlines, and more.

Explore free classifieds for Long Island, Nassu & Suffolk including cars, jobs, real estate, and buy and sell goods.